Oncolytics Biotech Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Oncolytics Biotech Inc. now
Current reporting with the operating signal separated from the noise.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2024 Earnings Call Transcript
Investors are testing whether Oncolytics Biotech Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript
Investors are testing whether Oncolytics Biotech Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Oncolytics Biotech Inc. (ONCY) CEO Matthew Coffey on Q2 2022 Results
The story matters when it changes Oncolytics Biotech Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ONCY filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Oncolytics Biotech Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →